56 related articles for article (PubMed ID: 9523237)
21. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines.
Dawson MJ; Trapani JA
J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA.
Kim KH; Shim JH; Seo EH; Cho MC; Kang JW; Kim SH; Yu DY; Song EY; Lee HG; Sohn JH; Kim J; Dinarello CA; Yoon DY
J Immunol Methods; 2008 Apr; 333(1-2):38-50. PubMed ID: 18252253
[TBL] [Abstract][Full Text] [Related]
23. Antibody Validation Strategy for Nuclear Receptors.
Katona B; Ibrahim A; Sundberg M; Williams C
Methods Mol Biol; 2019; 1966():79-99. PubMed ID: 31041740
[TBL] [Abstract][Full Text] [Related]
24. Isoform-specific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland.
Sugawara A; Yen PM; Qi Y; Lechan RM; Chin WW
Endocrinology; 1995 Apr; 136(4):1766-74. PubMed ID: 7895689
[TBL] [Abstract][Full Text] [Related]
25. Production and characterization of an estrogen receptor beta subtype-specific mouse monoclonal antibody.
Su JL; McKee DD; Ellis B; Kadwell SH; Wisely GB; Moore LB; Triantafillou JA; Kost TA; Fuqua S; Moore JT
Hybridoma; 2000 Dec; 19(6):481-7. PubMed ID: 11152400
[TBL] [Abstract][Full Text] [Related]
26. Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysis.
Enjoh T; Hizuka N; Perdue JF; Takano K; Fujiwara H; Higashihashi N; Marumoto Y; Fukuda I; Sakano K
J Clin Endocrinol Metab; 1993 Aug; 77(2):510-7. PubMed ID: 7688378
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody NM11 recognizes a C-terminal epitope shared by p300 and CBP.
Dallas PB; Yaciuk P; Moran E
Hybridoma; 1997 Jun; 16(3):273-5. PubMed ID: 9219037
[TBL] [Abstract][Full Text] [Related]
28. Generation and characterization of human delta-globin-specific monoclonal antibodies.
Xiao H; Zhu P; Liu B; Pan Q; Jiang X; Xu X; Fu N
Blood Cells Mol Dis; 2010 Mar; 44(3):127-32. PubMed ID: 20022528
[TBL] [Abstract][Full Text] [Related]
29. Production and characterization of monoclonal antibodies against the vasoconstrictive peptide human urotensin-II.
Su JL; Ao Z; Aiyar NV; Ellis B; Martin JD; Douglas SA; Kull FC
Hybrid Hybridomics; 2003 Dec; 22(6):377-82. PubMed ID: 14683597
[TBL] [Abstract][Full Text] [Related]
30. Production of a rat monoclonal antibody against Brg1.
Ohkawa Y; Harada A; Nakamura M; Yoshimura S; Tachibana T
Hybridoma (Larchmt); 2009 Dec; 28(6):463-6. PubMed ID: 20025509
[TBL] [Abstract][Full Text] [Related]
31. [Influence of hypoxia on peroxisome proliferator activated receptor alpha and its mechanisms].
Zhang HL; Zhang ZX; Xu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Sep; 26(9):535-8. PubMed ID: 14521756
[TBL] [Abstract][Full Text] [Related]
32. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer.
Inoue K; Kawahito Y; Tsubouchi Y; Yamada R; Kohno M; Hosokawa Y; Katoh D; Bishop-Bailey D; Hla T; Sano H
Anticancer Res; 2001; 21(4A):2471-6. PubMed ID: 11724309
[TBL] [Abstract][Full Text] [Related]
33. Docosahexaenoic acid membrane content and mRNA expression of acyl-CoA oxidase and of peroxisome proliferator-activated receptor-delta are modulated in Y79 retinoblastoma cells differently by low and high doses of alpha-linolenic acid.
Langelier B; Furet JP; Perruchot MH; Alessandri JM
J Neurosci Res; 2003 Oct; 74(1):134-41. PubMed ID: 13130515
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies against human Tudor-SN.
Saarikettu J; Ovod V; Vuoksio M; Grönholm J; Yang J; Silvennoinen O
Hybridoma (Larchmt); 2010 Jun; 29(3):231-6. PubMed ID: 20568998
[TBL] [Abstract][Full Text] [Related]
35. Development and characterization of monoclonal antibodies to spring viraemia of carp virus.
Chen ZY; Liu H; Li ZQ; Zhang QY
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):266-76. PubMed ID: 18378003
[TBL] [Abstract][Full Text] [Related]
36. Recommendations for description and validation of antibodies for research use.
Rizner TL; Sasano H; Choi MH; Odermatt A; Adamski J
J Steroid Biochem Mol Biol; 2016 Feb; 156():40-2. PubMed ID: 26655410
[No Abstract] [Full Text] [Related]
37. Peroxisome proliferator-activated receptors in diabetic nephropathy.
Kume S; Uzu T; Isshiki K; Koya D
PPAR Res; 2008; 2008():879523. PubMed ID: 19277201
[TBL] [Abstract][Full Text] [Related]
38. Plasma triglycerides are not related to tissue lipids and insulin sensitivity in elderly following PPAR-alpha agonist treatment.
Cree MG; Newcomer BR; Read LK; Sheffield-Moore M; Paddon-Jones D; Chinkes D; Aarsland A; Wolfe RR
Mech Ageing Dev; 2007 Oct; 128(10):558-65. PubMed ID: 17904198
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.
Reynders V; Loitsch S; Steinhauer C; Wagner T; Steinhilber D; Bargon J
Respir Res; 2006 Jul; 7(1):104. PubMed ID: 16875506
[TBL] [Abstract][Full Text] [Related]
40. Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control.
Youssef J; Badr M
J Biomed Biotechnol; 2004; 2004(3):156-166. PubMed ID: 15292582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
